Evidence map›Paper›PMID 32929226›Full record

ReviewExperimental & molecular medicine2020

Single-cell transcriptomics in cancer: computational challenges and opportunities.

Jean Fan, Kamil Slowikowski, Fan Zhang

Abstract readReview
In one paragraph

Review in Experimental & molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jean FanDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA. jeanfan@fas.harvard.edu.ORCID http://orcid.org/0000-0002-0212-5451
Kamil SlowikowskiCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, MA, USA.ORCID http://orcid.org/0000-0002-2843-6370
Fan ZhangCenter for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6102-2970

Funding

Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Statistical Methods for Characterizing Tumor Heterogeneity at the Single Cell LevelK00CA222750 · NCI · HARVARD UNIVERSITY · PI FAN, JEAN · 2018 to 2020
$249k
NCI NIH HHS K00 CA222750NHGRI NIH HHS T32 HG002295
6 · The paper itself

Abstract

Intratumor heterogeneity is a common characteristic across diverse cancer types and presents challenges to current standards of treatment. Advancements in high-throughput sequencing and imaging technologies provide opportunities to identify and characterize these aspects of heterogeneity. Notably, transcriptomic profiling at a single-cell resolution enables quantitative measurements of the molecular activity that underlies the phenotypic diversity of cells within a tumor. Such high-dimensional data require computational analysis to extract relevant biological insights about the cell types and states that drive cancer development, pathogenesis, and clinical outcomes. In this review, we highlight emerging themes in the computational analysis of single-cell transcriptomics data and their applications to cancer research. We focus on downstream analytical challenges relevant to cancer research, including how to computationally perform unified analysis across many patients and disease states, distinguish neoplastic from nonneoplastic cells, infer communication with the tumor microenvironment, and delineate tumoral and microenvironmental evolution with trajectory and RNA velocity analysis. We include discussions of challenges and opportunities for future computational methodological advancements necessary to realize the translational potential of single-cell transcriptomic profiling in cancer.

Indexed as

TranscriptomeBiomarkers, TumorCell CommunicationComputational BiologyGene Expression ProfilingGenomicsHigh-Throughput Nucleotide SequencingHumansNeoplasm GradingNeoplasmsOrgan SpecificitySequence Analysis, RNASingle-Cell AnalysisTumor MicroenvironmentBiomarkers, Tumor

Identifiers

PMID32929226
PMCPMC8080633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.